These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14525974)

  • 41. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands.
    Collie GW; Promontorio R; Hampel SM; Micco M; Neidle S; Parkinson GN
    J Am Chem Soc; 2012 Feb; 134(5):2723-31. PubMed ID: 22280460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Homocysteine accelerates senescence of endothelial cells via DNA hypomethylation of human telomerase reverse transcriptase.
    Zhang D; Sun X; Liu J; Xie X; Cui W; Zhu Y
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):71-8. PubMed ID: 25359865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Telomere length and hTERT expression in patients with colorectal carcinoma.
    Rosenberg R; Gertler R; Stricker D; Lassmann S; Werner M; Nekarda H; Siewert JR
    Recent Results Cancer Res; 2003; 162():177-81. PubMed ID: 12790332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanism of acridine-based telomerase inhibition and telomere shortening.
    Gunaratnam M; Greciano O; Martins C; Reszka AP; Schultes CM; Morjani H; Riou JF; Neidle S
    Biochem Pharmacol; 2007 Sep; 74(5):679-89. PubMed ID: 17631279
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relief of p53-mediated telomerase suppression by p73.
    Toh WH; Kyo S; Sabapathy K
    J Biol Chem; 2005 Apr; 280(17):17329-38. PubMed ID: 15734740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Inhibitory effect of hTERT dsRNA on telomerase activity in lung carcinoma cell line A549].
    Tian FJ; Wang ZY; Ma JY; Zhao YX; Lu W
    Ai Zheng; 2005 Mar; 24(3):257-61. PubMed ID: 15757523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism.
    Phatak P; Cookson JC; Dai F; Smith V; Gartenhaus RB; Stevens MF; Burger AM
    Br J Cancer; 2007 Apr; 96(8):1223-33. PubMed ID: 17406367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An anchor site-type defect in human telomerase that disrupts telomere length maintenance and cellular immortalization.
    Moriarty TJ; Ward RJ; Taboski MA; Autexier C
    Mol Biol Cell; 2005 Jul; 16(7):3152-61. PubMed ID: 15857955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Growth inhibition of BEL-7404 human hepatoma cells by expression of mutant telomerase reverse transcriptase.
    Zhang R; Wang X; Guo L; Xie H
    Int J Cancer; 2002 Jan; 97(2):173-9. PubMed ID: 11774261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses.
    Masutomi K; Possemato R; Wong JM; Currier JL; Tothova Z; Manola JB; Ganesan S; Lansdorp PM; Collins K; Hahn WC
    Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8222-7. PubMed ID: 15928077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acquired cellular resistance to flavopiridol in a human colon carcinoma cell line involves up-regulation of the telomerase catalytic subunit and telomere elongation. Sensitivity of resistant cells to combination treatment with a telomerase inhibitor.
    Incles CM; Schultes CM; Kelland LR; Neidle S
    Mol Pharmacol; 2003 Nov; 64(5):1101-8. PubMed ID: 14573759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transfer of the human telomerase reverse transcriptase (TERT) gene into T lymphocytes results in extension of replicative potential.
    Rufer N; Migliaccio M; Antonchuk J; Humphries RK; Roosnek E; Lansdorp PM
    Blood; 2001 Aug; 98(3):597-603. PubMed ID: 11468156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss.
    Ji HJ; Rha SY; Jeung HC; Yang SH; An SW; Chung HC
    Breast Cancer Res Treat; 2005 Oct; 93(3):227-36. PubMed ID: 16132531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Telomere length is related to alternative splice patterns of telomerase in thyroid tumors.
    Wang Y; Meeker AK; Kowalski J; Tsai HL; Somervell H; Heaphy C; Sangenario LE; Prasad N; Westra WH; Zeiger MA; Umbricht CB
    Am J Pathol; 2011 Sep; 179(3):1415-24. PubMed ID: 21763260
    [TBL] [Abstract][Full Text] [Related]  

  • 55. hTERT associates with human telomeres and enhances genomic stability and DNA repair.
    Sharma GG; Gupta A; Wang H; Scherthan H; Dhar S; Gandhi V; Iliakis G; Shay JW; Young CS; Pandita TK
    Oncogene; 2003 Jan; 22(1):131-46. PubMed ID: 12527915
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stabilization of telomere length and karyotypic stability are directly correlated with the level of hTERT gene expression in primary fibroblasts.
    Cui W; Aslam S; Fletcher J; Wylie D; Clinton M; Clark AJ
    J Biol Chem; 2002 Oct; 277(41):38531-9. PubMed ID: 12122013
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Telomerase immortalization of human myometrial cells.
    Condon J; Yin S; Mayhew B; Word RA; Wright WE; Shay JW; Rainey WE
    Biol Reprod; 2002 Aug; 67(2):506-14. PubMed ID: 12135889
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Catalytically active human telomerase mutants with allele-specific biological properties.
    Kim M; Xu L; Blackburn EH
    Exp Cell Res; 2003 Aug; 288(2):277-87. PubMed ID: 12915119
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Telomere length, telomerase activity, and expressions of human telomerase mRNA component (hTERC) and human telomerase reverse transcriptase (hTERT) mRNA in pulmonary neuroendocrine tumors.
    Nishio Y; Nakanishi K; Ozeki Y; Jiang SX; Kameya T; Hebisawa A; Mukai M; Travis WD; Franks TJ; Kawai T
    Jpn J Clin Oncol; 2007 Jan; 37(1):16-22. PubMed ID: 17060405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells.
    Sachsinger J; González-Suárez E; Samper E; Heicappell R; Müller M; Blasco MA
    Cancer Res; 2001 Jul; 61(14):5580-6. PubMed ID: 11454711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.